243
Views
11
CrossRef citations to date
0
Altmetric
Article

Pro-Oxidant Effect of Resveratrol on Human Breast Cancer MCF-7 Cells is Associated with CK2 Inhibition

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 2142-2151 | Received 13 Jun 2021, Accepted 25 Aug 2021, Published online: 14 Sep 2021

References

  • Green AK, Aviki EM, Matsoukas K, Patil S, Korenstein D, Blinder V. Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2018;172(2):247–63. doi:10.1007/s10549-018-4909-5
  • Ahmed SH. Safety of neoadjuvant chemotherapy for the treatment of breast cancer. Expert Opin Drug Saf. 2019;18(9):817–27. doi:10.1080/14740338.2019.1644318
  • Yun CW, Kim HJ, Lee SH. Therapeutic application of diverse marine-derived natural products in cancer therapy. Anticancer Res. 2019;39(10):5261–84. doi:10.21873/anticanres.13721
  • Efferth T . Editorial: Chemoprevention of cancer by natural products. Cancer Lett. 2019;459:13–4. doi:10.1016/j.canlet.2019.05.022
  • Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83(3):770–803. doi:10.1021/acs.jnatprod.9b01285
  • Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT, the International Natural Product Sciences Taskforce. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200–16. doi:10.1038/s41573-020-00114-z
  • Vervandier-Fasseur D, Latruffe N. The potential use of resveratrol for cancer prevention. Molecules. 2019;24(24):4506. doi:10.3390/molecules24244506
  • Shaito A, Posadino AM, Younes N, Hasan H, Halabi S, Alhababi D, Al-Mohannadi A, Abdel-Rahman WM, Eid AH, Nasrallah GK, et al. Potential adverse effects of resveratrol: a literature review. Int J Mol Sci. 2020;21(6):2084. doi:10.3390/ijms21062084
  • Elshaer M, Chen Y, Wang XJ, Tang X. Resveratrol: an overview of its anti-cancer mechanisms. Life Sci. 2018;207:340–9. doi:10.1016/j.lfs.2018.06.028
  • Ferraz da Costa DC, Fialho E, Silva JL. Cancer chemoprevention by resveratrol: The P53 tumor suppressor protein as a promising molecular target. Molecules. 2017;22:1014. doi:10.3390/molecules22061014
  • Chang LC, Yu YL. Dietary components as epigenetic-regulating agents against cancer. Biomedicine (Taipei). 2016;6(1):2–8. doi:10.7603/s40681-016-0002-8
  • Alamolhodaei NS, Tsatsakis AM, Ramezani M, Hayes AW, Karimi G. Resveratrol as MDR reversion molecule in breast cancer: an overview. Food Chem Toxicol. 2017;103:223–32. doi:10.1016/j.fct.2017.03.024
  • Sinha D, Sarkar N, Biswas J, Bishayee A. Resveratrol for breast cancer prevention and therapy: preclinical evidence and molecular mechanisms. Semin Cancer Biol. 2016;40-41:209–32. doi:10.1016/j.semcancer.2015.11.001
  • Sun Y, Zhou QM, Lu YY, Zhang H, Chen Q-L, Zhao M, Su S-B. Resveratrol inhibits the migration and metastasis of MDA-MB-231 human breast cancer by reversing TGF-β1-induced epithelial-mesenchymal transition. Molecules. 2019;24(6):1131. doi:10.3390/molecules24061131
  • Silva-Pavez E, Tapia JC. Protein kinase CK2 in cancer energetics. Front Oncol. 2020;10:893. doi:10.3389/fonc.2020.00893
  • Borgo C, Ruzzene M. Role of protein kinase CK2 in antitumor drug resistance. J Exp Clin Cancer Res. 2019;38(1):287. doi:10.1186/s13046-019-1292-y
  • Trembley JH, Chen Z, Unger G, Slaton J, Kren BT, Waes CV, Ahmed K. Emergence of protein kinase CK2 as a key target in cancer therapy. Biofactors. 2010;36(3):187–95. doi:10.1002/biof.96
  • Li D, Chen L, Hu Z, Li H, Li J, Wei C, Huang Y, Song H, Fang L. Alterations of microRNAs are associated with impaired growth of MCF-7 breast cancer cells induced by inhibition of casein kinase 2. Int J Clin Exp Pathol. 2014;7(7):4008–15.
  • de Sales NFF, da Costa LS, Carneiro TIA, Mizuno DA, Oliveira FL, Cabral LMC, Torres AG, El-Bacha T. Anthocyanin-rich grape pomace extract (Vitis vinifera L.) from wine industry affects mitochondrial bioenergetics and glucose metabolism in human hepatocarcinoma HepG2 cells. Molecules. 2018;23(3):611. doi:10.3390/molecules23030611
  • Gnaiger E . Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. Int J Biochem Cell Biol. 2009;41(10):1837–45. doi:10.1016/j.biocel.2009.03.013
  • Gomes L, Sorgine M, Passos CLA, Ferreira C, de Andrade IR, Silva JL, Atella GC, Mermelstein C, Fialho E. Increase in fatty acids and flotillins upon resveratrol treatment of human breast cancer cells. Sci Rep. 2019;9(1):13960. doi:10.1038/s41598-019-50416-5
  • Hu C, Liu Y, Teng M, Jiao K, Zhen J, Wu M, Li Z. Resveratrol inhibits the proliferation of estrogen receptor-positive breast cancer cells by suppressing EZH2 through the modulation of ERK1/2 signaling. Cell Biol Toxicol. 2019;35(5):445–56. doi:10.1007/s10565-019-09471-x
  • Baek SH, Ko JH, Lee H, Jung J, Kong M, Lee JW, Lee J, Chinnathambi A, Zayed ME, Alharbi SA, et al. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells. Phytomedicine. 2016;23(5):566–77. : doi:10.1016/j.phymed.2016.02.011
  • Ferraz da Costa DC, Campos NPC, Santos RA, Guedes-da-Silva FH, Martins-Dinis MMDC, Zanphorlin L, Ramos CHI, Rangel LP, Silva JL. Resveratrol prevents p53 aggregation in vitro and in breast cancer cells. Oncotarget. 2018;9(49):29112–22. doi:10.18632/oncotarget.25631
  • Lee WL, Huang JY, Shyur LF. Phytoagents for cancer management: regulation of nucleic acid oxidation, ROS, and related mechanisms. Oxid Med Cell Longev. 2013;2013:925804. doi:10.1155/2013/925804
  • Farhan M, Oves M, Chibber S, Hadi SM, Ahmad A. Mobilization of nuclear copper by green tea polyphenol epicatechin-3-gallate and subsequent prooxidant breakage of cellular DNA: implications for cancer chemotherapy. Int J Mol Sci. 2016;18(1):34. doi:10.3390/ijms18010034
  • Khan HY, Zubair H, Faisal M, Ullah MF, Farhan M, Sarkar FH, Ahmad A, Hadi SM. Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: a mechanism for cancer chemopreventive action. Mol Nutr Food Res. 2014;58(3):437–46. doi:10.1002/mnfr.201300417
  • Li W, Ma J, Ma Q, Li B, Han L, Liu J, Xu Q, Duan W, Yu S, Wang F, et al. Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway. Curr Med Chem. 2013;20(33):4185–94. : doi:10.2174/09298673113209990251
  • Kumar B, Iqbal MA, Singh RK, Bamezai RNK. Resveratrol inhibits TIGAR to promote ROS induced apoptosis and autophagy. Biochimie. 2015;118:26–35. doi:10.1016/j.biochi.2015.07.016
  • Cheng L, Yan B, Chen K, Jiang Z, Zhou C, Cao J, Qian W, Li J, Sun L, Ma J, et al. Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways. Oxid Med Cell Longev. 2018;2018:9482018. doi:10.1155/2018/9482018
  • Luo H, Yang A, Schulte BA, Wargovich MJ, Wang GY. Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage. PLoS One. 2013;8(3):e60065. doi:10.1371/journal.pone.0060065
  • Kirtonia A, Sethi G, Garg M. The multifaceted role of reactive oxygen species in tumorigenesis. Cell Mol Life Sci. 2020;77(22):4459–83. doi:10.1007/s00018-020-03536-5
  • NavaneethaKrishnan S, Rosales JL, Lee KY. ROS-mediated cancer cell killing through dietary phytochemicals. Oxid Med Cell Longev. 2019;2019:9051542. doi:10.1155/2019/9051542
  • Zhou C, Ding J, Wu Y . Resveratrol induces apoptosis of bladder cancer cells via miR‑21 regulation of the Akt/Bcl‑2 signaling pathway . Mol Med Rep. 2014;9(4):1467–73. doi:10.3892/mmr.2014.1950
  • Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel?Nat Rev Cancer. 2014;14(11):709–21. doi:10.1038/nrc3803
  • Qaiser F, Trembley JH, Kren BT, Wu JJ, Naveed AK, Ahmed K. Protein kinase CK2 inhibition induces cell death via early impact on mitochondrial function. J Cell Biochem. 2014;115(12):2103–15. doi:10.1002/jcb.24887
  • Bestgen B, Kufareva I, Seetoh W, Abell C, Hartmann RW, Abagyan R, Le Borgne M, Filhol O, Cochet C, Lomberget T, et al. 2-Aminothiazole derivatives as selective allosteric modulators of the protein kinase CK2. 2. structure-based optimization and investigation of effects specific to the allosteric mode of action. J Med Chem. 2019;62(4):1817–36. doi:10.1021/acs.jmedchem.8b01765
  • Hanif IM, Ahmad KA, Ahmed K, Pervaiz S. Involvement of reactive oxygen species in apoptosis induced by pharmacological inhibition of protein kinase CK2. Ann N Y Acad Sci. 2009;1171:591–9. doi:10.1111/j.1749-6632.2009.04916.x
  • Schneider CC, Hessenauer A, Götz C, Montenarh M. Montenarh: DMAT, an inhibitor of protein kinase CK2 induces reactive oxygen species and DNA double strand breaks. Oncol Rep. 2009;21(6):1593–7. doi:10.3892/or_00000392
  • Blanquer-Rosselló MD, Hernández-López R, Roca P, Oliver J, Valle A. Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells. Biochim Biophys Acta Gen Subj. 2017;1861(2):431–40. doi:10.1016/j.bbagen.2016.10.009

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.